Pantoprazole Accord Healthcare (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazole Accord Healthcare, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces gastric acid secretion and is used to manage conditions associated with excess stomach acid in adults.

GNH USA supplies Pantoprazole Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway and is used in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates healing of erosive lesions in the esophagus. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or arrhythmia. - Osteoporotic fractures: increased risk with long‑term use. - Liver enzyme elevation: hepatitis or cholestasis.

Before initiating therapy, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor electrolytes: especially magnesium during prolonged therapy. - Evaluate bone health: consider calcium/vitamin D supplementation if long‑term use is anticipated. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration. - Oral contraceptives: possible reduction in efficacy.